New York Times: The vital medical devices could be inexpensive and available over the counter. But efforts have stalled under the FDA.
![](https://static.wixstatic.com/media/a24c3d_2d320349fb464d82b8ae834351367139~mv2.png/v1/fill/w_980,h_1470,al_c,q_90,usm_0.66_1.00_0.01,enc_auto/a24c3d_2d320349fb464d82b8ae834351367139~mv2.png)
By now, we were supposed to be swiftly approaching the day when we could walk into a CVS or Walgreens, a Best Buy or Walmart, and walk out with a pair of quality, affordable hearing aids approved by the Food and Drug Administration.
Hearing aids, a widely needed but dauntingly expensive investment, cost on average $4,700 a pair. (Most people need two.) So in 2017, Congress passed legislation allowing the devices to be sold directly to consumers, without a prescription from an audiologist. The next step was for the FDA to issue draft regulations to establish safety and effectiveness benchmarks for these over-the-counter devices. Its deadline: August 2020. READ MORE
(Source: New York Times, 12/14/2020)
Comments